GW Link

Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Educational Grants - Schizophrenia RFP and Opioid Use Disorder RFP

Grants to USA Nonprofits and For-Profits for Continuing Medical
Education Programs Related to Schizophrenia and Opioid Abuse

Agency Type:

Foundation / Corporation

Funding Source:

Add to My Calendar 


Deadline Date:

05/30/19 Submissions are due at least 90 days in advance of the activity date.


Request a Grant Writer

Grants to USA nonprofit and for-profit organizations for accredited medical education programs for healthcare providers focused on the areas of schizophrenia and opioid dependence. Funding is intended for collaborative efforts between continuing medical education providers and professional organizations of practitioners focused on the treatment of individuals with opioid use disorder and serious mental illness, including schizophrenia. The goal of the grant is to contribute to a better and expanded understanding of the underlying mechanisms of disease and their relevance to medications that address those characteristics, as well as the overall treatment in a broad sense that includes psychosocial methods.

RFP Schizophrenia:
- Alkermes is looking to fund educational activities that evaluate clinical data of current and emerging antipsychotics, including their mechanisms of action, for the treatment of schizophrenia.
-Educational activities must be accredited (CME/CE), and collaborations between medical societies, academic institutions, and medical education companies are encouraged.
- Special attention will be given to programs that will reach audiences that are focused on treating persons with serious mental illnesses. Programs with additional funding sources are preferred.

RFP: Opioid Use Disorder:
- Alkermes is looking to fund independent educational programs regarding best practices for the use of long-acting injectable medications for the treatment of opioid use disorder, including best practices around withdrawal management and initiating these medications in real-world settings to improve outcomes in patients. Priority will be given to programs that develop enduring materials and that identify best practices based on the consensus view of experts in the fields of opioid use disorder research and clinical practice. Educational activities must be accredited (CME/CE), and collaborations between medical societies, academic institutions, and medical education companies are encouraged.
- Target audiences for this education include the addiction care team, including physicians, nurses, pharmacists and researchers. Programs with additional funding sources are preferred.

GrantWatch ID#:

GrantWatch ID#: 185713

Additional Eligibility Criteria:

Only US-based organizations may apply. Medical Education Grants may be awarded to (i) organizations qualified as nonprofit with tax exempt status under the U.S. Internal Revenue Code, or (ii) for-profit organizations who are accredited continuing medical education providers.

Alkermes’ educational grant funds may not be used to support overhead expenses of the applicant or for any other institution affiliated with the applicant. Grant requests must be unsolicited, should typically have multiple funders, support education on a wide range of treatment options, not promote a particular medicine and must not provide nor promise to Alkermes any tangible benefit.

Alkermes will not support funding for meals, unless they are modest buffet meals, snacks or coffee that are made available to all attendees of the Educational Activity and where the identity of the Healthcare Participants who partake is not separately identifiable.

Educational grants will not be awarded to or for:
- Individuals or a healthcare professional’s private practice
- Any charity or foundation associated with or controlled by an individual healthcare professional or healthcare professional’s private practice
- Organizations that discriminate on the basis of race, color, sex, sexual orientation, religion, age, national origin or disability
- Fundraising event of a potential customer (e.g., treatment center or hospital) where the proceeds are being used to cover general operational and routine business costs
- Events that have already occurred
- Political organizations, campaigns and activities
- Religious organizations or groups whose activities are primarily sectarian in purpose
- Programs or proposals that supplement an organization’s income or offset its expenses in a manner that benefits, directly or indirectly, a physician’s compensation

Pre-Application Information:

Proposals must be submitted to our online portal between the dates May 1st – May 30th, 2019. Any proposal submitted before or after this window period will not be eligible for RFP consideration. Please reference “2019-RFP-SZ-01” in your Request Title for the Schizophrenia RFP and “2019-RFP-AD-02” for the Opioid Disorder RFP.

Recipients will be selected by the Alkermes Grants Review Committee, and recipients will be notified in June 2019.


Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Register and apply online starting May 1:

If you have any questions please email or

Alkermes, Inc.
MedEd Grants Administrator, Medical Affairs
852 Winter Street
Waltham, MA 02451

URL for Full Text (RFP):

Geographic Focus:

USA: Alabama;   Alaska;   Arizona;   Arkansas;   California;   Colorado;   Connecticut;   Delaware;   Florida;   Georgia;   Hawaii;   Idaho;   Illinois;   Indiana;   Iowa;   Kansas;   Kentucky;   Louisiana;   Maine;   Maryland;   Massachusetts;   Michigan;   Minnesota;   Mississippi;   Missouri;   Montana;   Nebraska;   Nevada;   New Hampshire;   New Jersey;   New Mexico;   New York City;   New York;   North Carolina;   North Dakota;   Ohio;   Oklahoma;   Oregon;   Pennsylvania;   Rhode Island;   South Carolina;   South Dakota;   Tennessee;   Texas;   Utah;   Vermont;   Virginia;   Washington, DC;   Washington;   West Virginia;   Wisconsin;   Wyoming